March 18, 2026

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by GoodRx Holdings, Inc. (copy attached), which we understand will

be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of GoodRx

Holdings, Inc. dated March 14, 2026. We agree with the statements concerning our Firm contained

therein.

Very truly yours,

/s/PricewaterhouseCoopers LLP

Los Angeles, California

Attachment